Cargando…
Duality of β-glucan microparticles: antigen carrier and immunostimulants
Designing efficient recombinant mucosal vaccines against enteric diseases is still a major challenge. Mucosal delivery of recombinant vaccines requires encapsulation in potent immunostimulatory particles to induce an efficient immune response. This paper evaluates the capacity of β-glucan microparti...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4898424/ https://www.ncbi.nlm.nih.gov/pubmed/27330289 http://dx.doi.org/10.2147/IJN.S101881 |
_version_ | 1782436354656829440 |
---|---|
author | Baert, Kim De Geest, Bruno G De Greve, Henri Cox, Eric Devriendt, Bert |
author_facet | Baert, Kim De Geest, Bruno G De Greve, Henri Cox, Eric Devriendt, Bert |
author_sort | Baert, Kim |
collection | PubMed |
description | Designing efficient recombinant mucosal vaccines against enteric diseases is still a major challenge. Mucosal delivery of recombinant vaccines requires encapsulation in potent immunostimulatory particles to induce an efficient immune response. This paper evaluates the capacity of β-glucan microparticles (GPs) as antigen vehicles and characterizes their immune-stimulatory effects. The relevant infectious antigen FedF was chosen to be loaded inside the microparticles. The incorporation of FedF inside the particles was highly efficient (roughly 85%) and occurred without antigen degradation. In addition, these GPs have immunostimulatory effects as well, demonstrated by the strong reactive oxygen species (ROS) production by porcine neutrophils upon their recognition. Although antigen-loaded GPs still induce ROS production, antigen loading decreases this production by neutrophils for reasons yet unknown. However, these antigen-loaded GPs are still able to bind their specific β-glucan receptor, demonstrated by blocking complement receptor 3, which is the major β-glucan receptor on porcine neutrophils. The dual character of these particles is confirmed by a T-cell proliferation assay. FedF-loaded particles induce a significantly higher FedF-specific T-cell proliferation than soluble FedF. Taken together, these results show that GPs are efficient antigen carriers with immune-stimulatory properties. |
format | Online Article Text |
id | pubmed-4898424 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-48984242016-06-21 Duality of β-glucan microparticles: antigen carrier and immunostimulants Baert, Kim De Geest, Bruno G De Greve, Henri Cox, Eric Devriendt, Bert Int J Nanomedicine Original Research Designing efficient recombinant mucosal vaccines against enteric diseases is still a major challenge. Mucosal delivery of recombinant vaccines requires encapsulation in potent immunostimulatory particles to induce an efficient immune response. This paper evaluates the capacity of β-glucan microparticles (GPs) as antigen vehicles and characterizes their immune-stimulatory effects. The relevant infectious antigen FedF was chosen to be loaded inside the microparticles. The incorporation of FedF inside the particles was highly efficient (roughly 85%) and occurred without antigen degradation. In addition, these GPs have immunostimulatory effects as well, demonstrated by the strong reactive oxygen species (ROS) production by porcine neutrophils upon their recognition. Although antigen-loaded GPs still induce ROS production, antigen loading decreases this production by neutrophils for reasons yet unknown. However, these antigen-loaded GPs are still able to bind their specific β-glucan receptor, demonstrated by blocking complement receptor 3, which is the major β-glucan receptor on porcine neutrophils. The dual character of these particles is confirmed by a T-cell proliferation assay. FedF-loaded particles induce a significantly higher FedF-specific T-cell proliferation than soluble FedF. Taken together, these results show that GPs are efficient antigen carriers with immune-stimulatory properties. Dove Medical Press 2016-05-31 /pmc/articles/PMC4898424/ /pubmed/27330289 http://dx.doi.org/10.2147/IJN.S101881 Text en © 2016 Baert et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
spellingShingle | Original Research Baert, Kim De Geest, Bruno G De Greve, Henri Cox, Eric Devriendt, Bert Duality of β-glucan microparticles: antigen carrier and immunostimulants |
title | Duality of β-glucan microparticles: antigen carrier and immunostimulants |
title_full | Duality of β-glucan microparticles: antigen carrier and immunostimulants |
title_fullStr | Duality of β-glucan microparticles: antigen carrier and immunostimulants |
title_full_unstemmed | Duality of β-glucan microparticles: antigen carrier and immunostimulants |
title_short | Duality of β-glucan microparticles: antigen carrier and immunostimulants |
title_sort | duality of β-glucan microparticles: antigen carrier and immunostimulants |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4898424/ https://www.ncbi.nlm.nih.gov/pubmed/27330289 http://dx.doi.org/10.2147/IJN.S101881 |
work_keys_str_mv | AT baertkim dualityofbglucanmicroparticlesantigencarrierandimmunostimulants AT degeestbrunog dualityofbglucanmicroparticlesantigencarrierandimmunostimulants AT degrevehenri dualityofbglucanmicroparticlesantigencarrierandimmunostimulants AT coxeric dualityofbglucanmicroparticlesantigencarrierandimmunostimulants AT devriendtbert dualityofbglucanmicroparticlesantigencarrierandimmunostimulants |